Patents by Inventor Michel Goldberg

Michel Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES OF IL-2
    Publication number: 20100273723
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: January 21, 2010
    Publication date: October 28, 2010
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2
    Patent number: 7704490
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: April 27, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2
    Patent number: 7662368
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: February 16, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2
    Patent number: 7101965
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: September 5, 2006
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20060018873
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof
    Patent number: 6929791
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: August 16, 2005
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20020044935
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: February 6, 2001
    Publication date: April 18, 2002
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method for producing factor for the stimulation of the liver cell proliferation rate
    Patent number: 4377514
    Abstract: A process for making factor for stimulating the rate of proliferation of liver cells comprising homogenizing animal Peyer's glands, adjusting pH to about 5.5, thermally denaturing the product and recovering the desired factor in the supernatant by centrifugation.
    Type: Grant
    Filed: October 5, 1981
    Date of Patent: March 22, 1983
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften E.V.
    Inventors: Gerhard Ruhenstroth-Bauer, Michel Goldberg, Hubertus Schneider
  • Drug for enhancing liver growth and method of preparing same
    Patent number: 4341765
    Abstract: A factor which causes an increase in the number of liver cells through increased cell division activity, obtained by homogenizing the remaining livers of partially hepatectomized animals, subjecting the homogenate to acidification to pH=5.5 and then heat treatment at 95.degree. C., and centrifuging said homogenate. After such treatment, the factor is contained in the supernatant. The factor is a neuraminic-acid-free protein with a molecular weight of approximately 30,000 to 50,000 D. An extract containing the factor also can be obtained from the blood plasma of hepatectomized animals, when the plasma in addition to the described steps further is treated with neuraminidase. Similarly, an extract containing the factor can be obtained from the livers or the plasma of non-hepatectomized fetal or very young animals.
    Type: Grant
    Filed: March 17, 1980
    Date of Patent: July 27, 1982
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften E.V.
    Inventors: Gerhard Ruhenstroth-Bauer, Michel Goldberg, Siegfried Silz, Wolfgang Strecker
  • Drug for stimulating the rate of proliferation of liver cells and method for producing same
    Patent number: 4330528
    Abstract: A drug for stimulating the rate of proliferation of liver cells having as s active ingredient a blood plasma extract (NP) and a method of preparing such a drug wherein blood plasma is first acidified to a pH of 5.5, then heat denatured at approximately 95.degree. C. and subsequently centrifuged to provide the extract.
    Type: Grant
    Filed: July 3, 1980
    Date of Patent: May 18, 1982
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften E.V.
    Inventors: Gerhard Ruhenstroth-Bauer, Michel Goldberg